Ligand-receptor interactions have essential roles in a plethora of biological processes, and they are active targets of drug development. Ligand binding on the surface of the cell transduces prosurvival, death-inducing and many other signals across the cell membrane into cells. The most successful approaches to identify ligand-receptor interactions have been affinity chromatography and, for weak interactions, ecto-domain alkaline phosphatase fusion protein binding and labeling in combination with expression cloning [1] [2] [3] [4] . However, the many technical difficulties associated with producing and analyzing transmembrane protein receptors have limited the rate of the identification of their binding partners 5 . Further, antibody-based purification of intact ligand-receptor pairs from tissue extracts is challenging and can be problematic for many interactions. Even when antibody-based approaches work, there is often massive background, which makes data analysis challenging.
There have been many recent technological developments toward the efficient identification of intracellular proteinprotein interactions such as recombinant epitope tags and yeast two-hybrid assays. However, little progress has been made in the development of well-accepted procedures for the identification of extracellular protein-protein interactions. Protein identification by MS facilitates efficient analysis and identification of co-purifying interacting proteins 6, 7 . MS-based approaches also show further progress as highlighted by a recent chemoproteomic approach, which successfully identified several diverse classes of cell surface protein-protein interactions 8 . However, nearly all previous attempts to identify ligand-receptor interactions have been limited by their abundance and interaction affinities, as the eluted material is inspected by SDS-PAGE followed by gel slicing and MS analysis 9 . For these reasons, the identification of ligand receptors has been biased toward abundant proteins with high binding affinities.
We developed a straightforward discovery-based MS workflow to circumvent the previous challenges associated with the identification of ligand-receptor interactions. We have successfully used our ecto-Fc MS approach to identify multiple synaptic ligandreceptor interactions, which have proven to be excellent starting points for the discovery of new and unexpected biology [10] [11] [12] .
Overview of the protocol Our approach starts with the generation of recombinant protein baits, which contain receptor extracellular domains fused to the Fc region of human IgG. These recombinant proteins or 'ecto-Fcs' are produced by transient or stable transfection of HEK293T cells and purified from the culture medium by gravity flow chromatography with protein A resin. Subsequently, the ecto-Fcs are eluted, concentrated and characterized by standard SDS-PAGE and MS analyses. The ecto-Fcs proteins then serve as baits for batch-binding assays with prey proteins extracted from rodent tissues. The bait proteins bound to interaction partners are re-captured with protein A resin, washed extensively and eluted. Because ecto-Fc MS requires artificially large quantities of the bait Fc protein in the binding reaction, there are potential concerns regarding the effect on binding competition. Thus, a high-affinity interaction may be outcompeted by one with a lower affinity because of the high concentration of the bait protein available for binding. Purified proteins are precipitated and processed into peptides in solution, and peptide mixtures are then pressure-loaded directly onto multidimensional LC columns and analyzed by LCLC-MS/MS with ion or orbitrap mass spectrometers. As these samples have relatively
Ecto-Fc MS identifies ligand-receptor interactions through extracellular domain Fc fusion protein baits and shotgun proteomic analysis
low complexity, they can be deeply analyzed to generate confident semiquantitative measures of abundance based on normalized spectral counts for nearly all the proteins present.
Once a candidate receptor is identified, we generate the corresponding ecto-Fc and perform reciprocal ecto-Fc MS. Further, we confirm direct protein-protein interactions with the same purified proteins with in vitro binding experiments. We have also shown that we can identify multimeric ligand-receptor networks containing more than two proteins 12 . We use bioinformatics to probe the protein lists by examining the abundance of potential interacting proteins relative to the amount of bait and negative control Fc-alone purifications. Through these efforts, we have found that this protocol provides a robust, straightforward method to identify ligand-receptor interactions (Fig. 1) .
Advantages of the method
The major advantages of the ecto-Fc MS protocol to those previously published is speed, sensitivity and comprehensiveness of the analysis:
(i) Production of ecto-Fc proteins by DNA transfection of HEK293T cells is an accessible approach for generating ample recombinant extracellular domain protein baits, which are properly folded and post-translationally modified by cysteine bonding and glycosylation 13 T1 T2 T3  T1 T2 T3 T1 T2 T3 T1 T2 easily identified by known morphological structural landmarks or complete voxelation of the brain on the basis of uniform x, y and z, coordinates (3D grid) as the tissue source for the prey proteins. The MS analysis suggested here provides semiquantitative measures of protein abundance within a single purification. One way to increase the throughput of our system could be to multiplex the MS analysis with isotopic peptide tags, which would allow affinity purifications to be analyzed simultaneously 14 . 15, 16 . Note that the FLAG sequence is also cleavable, as DDDDK is the enterokinase recognition sequence. A variety of Fc vectors such as the pFUSE-Fc family, pCMV6-AN-FC or Ig/pEG-BOS are available commercially or through Addgene.
Experimental design
Ecto-Fc bait protein production. The efficiency and yield of Fc protein production varies depending on the sequence and protein of interest. We tend to scale up the number of HEK293T dishes transfected to surmount this hurdle. We have found that for most ecto-Fcs transient transfection of HEK293T cells with cationic polymer polyethylenimine (PEI) is a productive approach. Typically, 20-50 15-cm plates will yield protein in a range from 100 µg to several milligrams (volumetrically 0.1-5 mg per liter of medium). The amount of bait protein produced may be limited by the steric hindrance from the dimeric nature of the Fc fragment. We have also found that generating stable cell lines using suspension-adapted cells can markedly improve yield, but in general they are not necessary 17 .
Ecto-Fc protein assessment. The final ecto-Fc yield is determined by standard Bradford assay. The integrity of the recombinant proteins is assessed by SDS-PAGE with Coomassie blue staining (Fig. 2a,b) . If further characterization of the ecto-Fc is needed, we directly analyze the purified baits by LCLC-MS/MS. MS analysis of the purified ecto-Fc bait alone aids in the determination of the exact amino terminus (Fig. 2c) .
It may be helpful to qualitatively examine the binding activities of the ecto-Fc on the surface of cultured cells from the tissue of interests. Strong binding suggests the existence of a high-affinity interaction, and the identity of this receptor(s) may be revealed by ecto-Fc MS.
Prey protein preparation. Biochemical preparation of the 'prey' extract is one of the most crucial steps in this protocol. If the receptor protein of interest is not sufficiently extracted and solubilized from the tissue, it will not be available for binding or identification by MS. We suggest several different approaches to surmounting this potential issue (Step 26).
Binding reaction. We have found 50-100 µg of ecto-Fc bait protein to be the optimal starting point. It is not necessary to determine the precise prey protein concentration. Proper binding conditions (buffer components and so on) should be worked out empirically, as protein binding activity from tissue extracts will vary. For many candidate ligands, it will be necessary to perform replicate analysis to reveal confident candidate receptors (Fig. 1) .
Sample preparation for MS. The purified proteins can be precipitated with 2,2,2-trichloroacetic acid (TCA)/acetone or methanol/ chloroform with standard protocols. The precipitated proteins are solubilized, denatured, reduced and alkylated in solution 12 . We have found overnight digestion with 2 µg of sequence-grade trypsin at 37 °C with shaking to be the most reliable option to ensure complete digestion. It is crucial that the samples be acidified to a final concentration of 5% (vol/vol) formic acid before centrifugation and loading onto the LCLC column.
Multidimensional LCLC chromatography with online tandem MS analysis. Multidimensional protein identification technology is a straightforward method to deeply analyze complex protein mixtures, and it has been previously described in detail [18] [19] [20] [21] [22] . The necessary equipment includes an ion-trap mass spectrometer and a quaternary HPLC pump. We show that multidimensional LC separation is a powerful approach for the comprehensive analysis of the affinity-purified material. We also acknowledge that single-phase LC separations with fast scanning MS should also be comparable in regard to the number of protein identifications. To effectively identify low-abundance or low-affinity interactions, it is crucial that the MS analysis be near comprehensive. Deep analytical sampling of the purified material by MS/MS will substantially boost the confidence of the semiquantitative measures of the affinity-purified material.
Controls.
The suggested negative control for ecto-Fc MS is simply an IgG Fc protein without any ecto domain fused. This is a straightforward and inexpensive control, which should be performed in parallel for every ecto-Fc purification. We have found that dissimilar ecto-Fcs, especially if their domains belong to the same fold family, can also serve as excellent negative controls for one another. For example, prey proteins abundantly identified in all or nearly all ecto-Fc experiments are not likely to be true ligands and should be ignored or manually validated in other experiments (Fig. 1) .
Protein database search, data filtering and data set comparisons. Bioinformatics has an essential role in the analysis and interpretation of MS data. There are multiple software packages that bundle protein database search, filtering and data set comparisons; however, we are most familiar with those described here. Many informatics tools can lead users to the correct answers; however, the most important consideration is that the users understand how the tools are working and how to interpret the data sets 23 . The protein database used for the database search is absolutely crucial for the success of ecto-Fc MS; if the amino acid sequence corresponding to the receptor of interest is not present in the database, it cannot be identified. For the most comprehensive MS analysis of ecto-Fc bait proteins, a custom protein database entry should be added to the protein database. The entry should contain the exact amino acid sequence of the cloned bait with the suggested flag/prolactin signal peptide, and the Fc sequence concatenated. Filtering each data set by target-decoy with reversed protein sequences is also very important, as the inclusion of many weak or suspect protein identifications may lead to misinterpretation of the data.
There are many options when it comes to bioinformatic analysis of proteomic data sets, each with its own unique strengths and weaknesses. The first software decision is the search engine. We are most familiar with Sequest/Prolucid, but also recognize that Mascot, X! Tandem and OMSSA all can achieve confident protein identifications sufficient for a successful ecto-Fc MS experiment [24] [25] [26] . This protocol requires some label-free semiquantitative measure of abundance to be provided from the analysis software, which could be in the form of spectral counts, ion intensities or other measures. Further, it is also required that multiple sample analyses (data sets) be directly compared, for example, against the Fc alone for a negative control. There are many software packages that provide direct comparisons between data sets and include Scaffold (Proteome Software), Proteome Discover (Thermo Scientific), Maxquant, PatternLab, MStats and Peaks Q (Bioinformatics Solutions) [27] [28] [29] .
Data set interpretation. The first step is to sort the identified proteins in each ecto-Fc MS data set in descending order on the basis of the number of spectral counts 30 , or similarly normalized spectral counts 31 . The bait protein should be the most abundant protein present, and it is typically identified by hundreds to a few thousand spectral counts. By comparing the abundance of each protein relative to the ecto-Fc bait, an enrichment factor is calculated.
Manually interrogate the list by considering each protein carefully, using abundance to guide the interpretation. True hits should have transmembrane domains or be secreted. We have found some receptors to be the second-most-abundant proteins in the unfiltered data sets, whereas others require background subtraction and careful assessment 10, 11 . Unfortunately, not every ligand-receptor pair can be easily identified by reciprocal ecto-FC MS. This is often because one ligand is of very low abundance (such as Lrrtm2) and is challenging to effectively isolate from the complex tissue extract. A typical ecto-Fc MS experiment will reveal hundreds of protein identifications from a single affinity purification experiment owing to the high sensitivity of current mass spectrometers. Nearly all these proteins are not true receptors. Rather, they constitute nonspecific background proteins or indirectly interacting proteins, which are challenging to interpret and should be ignored. For some ligands, ecto-Fc MS may fail to show any candidate receptors or only false interaction artifacts, which have arisen as a consequence of the highly abundant bait protein. One option is to try a His-tagged recombinant protein (His is much smaller than Fc) in a similar way but with Ni or antiHis antibodies to couple the bait protein to the beads.
Validation of new ligand-receptor interactions.
Additional independent binding experiments aimed to validate the interaction are needed for the accurate description of a new ligand/receptor interaction. The first experiment that we suggest to validate a new interaction is to test whether the ecto-Fc bait protein will bind to the cell surface after transfection of the new protein of interest. Binding levels can be easily visualized by traditional cell surface immuonofluorescence with anti-Fc antibodies. Additional binding experiments (such as co-immunoprecipitation after transient transfection or direct binding experiments with purified proteins) will indicate whether these interactions are direct or indirect. When describing a new interaction, it is also valuable to determine which domains are required for the interaction, and binding assays with deletion mutants or titration of competitive peptides could prove to be revealing.
An important benchmark for the proper description and characterization of a new ligand/receptor interaction is the measurement of the binding affinity. Although technical limitations may hinder the accurate affinity measurement of some ligand/receptor interactions, it is an essential follow-up experiment necessary to characterize new protein-protein interactions. There are many potential approaches that can yield an estimate of the binding affinity (more precisely accurate association and dissociation binding constants) between a ligand and receptor; these include surface plasmon resonance, biolayer interferometry or isothermal titration calorimetry. Human tissue has also been found to be compatible with ecto-Fc MS, and it represents a key extension of the assay with rodent tissue extracts. 
MaterIals

REAGENTS
Refrigerated benchtop centrifuge (Eppendorf 5415R) Electrospray ion-trap/orbitrap mass spectrometer (Thermo Fischer Scientific) Nano-HPLC system (Agilent Technologies 1200) Pressure injection cell 'gas bomb' (Next Advance, cat. no. PC77) ! cautIon Exercise care when using high-pressure gas.
Compressed gas (Helium for bomb) ! cautIon Make sure that proper training has been provided for all those using high-pressure gas, as potentially serious physical injures can occur from misuse; safety glasses are a must. 
Rodent tissue and protein solubilization
We have focused our efforts on rodent brain tissue, and we have had the most success with using 5-10 P21 rat brains (P21 rat brain weighs ~1.5 g and adult rat brain weighs 2.6 g) per Fc. However, we have also had success with ecto-Fc MS with only a single brain as input material. We suggest these values as a starting point for future experiments with other tissues. Adult brain tissue becomes increasingly myelinated and is a challenging tissue source from which to effectively extract prey proteins. The amount of tissue required for a successful purification is also dependent on how well it is solubilized and on the absolute abundance of the receptor. To increase protein extraction efficiency, we have had success increasing the Triton X-100 concentration (up to 5%, vol/vol) and increasing extraction incubation periods to overnight. The use of more aggressive detergents and higher temperatures during the extraction step should solubilize more protein; however, the proteins may become denatured and unable to efficiently bind the bait. Intact mammalian tissues can be stored at −80 °C for up to 1 year. ! cautIon Research involving the use of vertebrate animals must be reviewed by the investigator's institutional ethical review board to avoid all unnecessary discomfort or pain to the animals and to determine
whether alternatives to animal research exist. All animal experiments should be performed in accordance with relevant institutional and governmental guidelines. The regulations of protocols approved by the investigator's institutional animal research review committee and all personnel involved should be fully trained in proper animal handling. Triton X-100 Dilute Triton X-100 to 10% (10×) in buffer matched to tissue homogenization buffer.  crItIcal This buffer should be freshly made for each purification. Chill the buffer to 4 °C before use. Buffer 1 (ecto-Fc production column wash) Mix 50 mM HEPES (pH 7.4), 300 mM NaCl and 0.5× (one pellet for twice the buffer volume recommended by Sigma-Aldrich) protease inhibitors.
(The protease inhibitors come as a solid pellet; 1× is one tablet in either 10 or 50 ml of buffer, depending on whether you are using a 10× or a 50× tablet. In this protocol, you can use one tablet for 20 or 100 ml, respectively.)  crItIcal This buffer should be freshly made for each purification, chilled to 4 °C before use and kept in use for 1 week. (Fig. 3) .
Multidimensional protein identification technology (MudPIT) LCLC columns
Cut Kasil frit such that 1-2 mM remains. Pack Kasil frit with 2.5 cm of strong cation exchange (SCX) resin in methanol on the bomb (i.e., the pressure injection cell 'gas bomb'). Pack the frit with 2.5 cm of reversed-phase (RP) resin in methanol on bomb. ! cautIon Use caution when working with high-pressure gas; do not exceed 1,000 p.s.
i. (ref. 32).
Check all connections before turning on the gas, as serious injury is possible; always wear safety glasses (Fig. 3) . Washing LC columns All HPLC columns should be washed for 15 min with HPLC buffer B and then for 15 min with HPLC buffer A before sample loading. After loading LCLC columns with sample, wash them for ≥30 min with HPLC buffer A. HPLC and mass spectrometer operation Generate LCLC-MS methods and assemble the analysis run sequence. The first step (individual method file) is a linear gradient of increasing percentages of HPLC buffer B (from 0 to 100%) over 90 min. All subsequent steps are 120 min; start with a 3-5-min 'salt bump' of HPLC buffer C and then proceed with a shallow gradient up to 60 or 100% B. For this protocol, we recommend a five-step analysis (percentage buffer C = 20, 40, 60 and 100%).
Steps 2-5 provide multidimensional chromatographic separation, which facilitates in-depth sample analysis. For additional details on the MudPIT approach, please see previously published descriptions 18, 19, 33 . Electrospray ion-trap mass spectrometer should be tuned and calibrated as per the manufacturer's specifications approximately once a month, and it should be cleaned several times per year. It is our experience that linear trap quadrupole (LTQ) mass spectrometers are very well suited for this protocol. Faster scanning high-resolution instruments, operated in Velos Orbitrap or Tribrid Fusion mass spectrometers, may improve results but are not required. The detailed settings for each of these instruments will vary, but in general we recommend a distal 2.4-kV spray voltage, a full-scan MS from 400-1,800 m/z and an intensity threshold of 1,000 for MS/MS. When possible, we reject those ions for MS/MS that are singly charged, as well as those for which the charge state cannot be assigned; we recommend using dynamic exclusion when possible 20 . For LTQ, we recommend 5-10 MS/MS per MS and for Velos we recommend 20. 
4|
In a 15-ml conical tube, add the following solutions in this order: 6 ml of Opti-MEM, 100 µg of the DNA for transfection dissolved in water and 600 µl of PEI. Vortex and allow the mixture to stand in a hood for 10 min.
5| Add 580 µl of the solution prepared in Step 4 dropwise to each dish prepared in Step 2.
6|
Replace the medium after 6 h with 25 ml of serum-free prewarmed Opti-MEM per 15-cm plate.  crItIcal step Changing the medium to Opti-MEM is crucial in order to prevent IgG contamination from FCS.
7|
Incubate the cells at 37°C for >5 d.  crItIcal step HEK293T cells should be inspected by light microscopy to monitor viability and attachment starting at day 3.
If the cells are healthy and remain attached, additional culturing may increase the Fc yield.
? trouBlesHootInG 8| Collect the medium in multiple 50-ml conical tubes; it is likely that 20-22 ml of medium will be recovered per plate. Distribute the total volume equally across multiple tubes as needed. Clarify cellular debris by centrifugation at 1,500g for 10 min at 4 °C. It is not uncommon to observe a small debris pellet after the spin. Filter the supernatant using a 250-ml filter flask and add 0.5× protease inhibitors (one pellet for twice the buffer volume recommended by Sigma-Aldrich).  pause poInt For most proteins (without aggregation), the conditioned TC medium can be stored at 4 °C for up to 2 weeks.
purification of the ecto-Fc proteins • tIMInG 2-3 d 9| For each Fc protein preparation (100 µg of transfected DNA plasmid), wash 1 ml of protein A resin in cold PBS three times with low-speed spins (500g for 5 min at 4 °C). Transfer the washed beads to an Econo-Column and use gravity flow to further wash and pack the resin bed with cold PBS (Fig. 2a) .
10| Add serum-free conditioned medium to the column by gravity flow chromatography, making sure to capture the flow-through. Once the medium has completely passed through the column, immediately re-apply the flow-through to the column for a total of two purification rounds. ? trouBlesHootInG 11| Wash the column with 500 ml of cold buffer 1.
12|
Elute ecto-Fc proteins twice with 10× 1 ml of Pierce elution buffer. Capture the eluted material and immediately neutralize with 100 µl of 1 M HEPES, pH 7.5. Wait until the wash buffer has near completely drained from the column before adding the elution buffer.
13| Pool elutions and transfer to a Slide-A-Lyzer using a needle syringe. Dialyze at 4 °C overnight with two buffer changes according to the manufacturer's instructions.  crItIcal step Make sure to remove all excess air in the cassette to ensure maximal membrane surface area for buffer exchange.
14| Concentrate ecto-Fc proteins with the appropriate molecular weight cutoff (MWCO) Ultra centrifuge units at 4 °C. As per the manufacturer instructions, efficient recovery is obtained with a MWCO ~3× smaller than the protein of interest. 100 kDa needs a MWCO of 30 kDa (see the manufacturer's instructions for more details). Add glycerol to a 10% (vol/vol) final concentration for cryoprotection if you are storing the proteins at −80 °C.  pause poInt The purified proteins can be divided into aliquots and stored at −80 °C for 1 year; for short-term storage ≤3 months, store the proteins at 4 °C.
affinity purification of receptor • tIMInG 1 d 27| For each ecto-Fc bait, distribute 12-13 ml of clarified tissue extract to a 15-ml conical tube.  crItIcal step It is very important that the binding reaction be performed with a nearly full tube; smaller volumes are likely to result in foaming, which can cause protein denaturation and interfere with efficient affinity capture of prey proteins.
28|
Transfer an entire 100 µg of ecto-Fc bead slurry preparation (product of Steps 18-24) to each conical tube.
29|
Rinse each Fc tube with 500 µl of buffer 2 to ensure recovery of residual beads and Fc protein.
Transfer each rinse to the appropriate conical tube.
30|
Incubate the mixture at 4 °C overnight with end-over-end rotation.
31|
Recover the tubes and spin them at 500g for 5 min at 4 °C.  crItIcal step Inspect the turbidity of the extract; it should be free of clumps and particulate matter. This is an indication of precipitation and may cause the affinity purification column to clog.
32|
Gently remove 10 ml of unbound extract with a pipette, and discard without disturbing the beads.  crItIcal step We have found that removing a large portion of the unbound material at this step is critically important to ensure that the nonspecific binding is kept to a minimal level.
33|
Gently resuspend the beads in the conical tube using a glass transfer pipette, and slowly transfer the entire volume to a capped poly prep column. Allow sufficient time such that the beads will accumulate in an even bed at the bottom of the column. This entire step should be performed at 4 °C and with care to recover as much of the bead slurry as possible.  crItIcal step When transferring the beads to the column, ensure that the bead slurry is carefully ejected from the pipette while slowly circling the column top to ensure an even bead bed, which is well packed and uniform.
34|
Remove the column plug while carefully monitoring the buffer front as the extract flows through the beads and out of the column exit port. Allow the extract to flow until the extract front is just above the bead bed, at which time re-cap the column.  crItIcal step It is very important to allow as much of the extract to flow through the beads as possible. Residual extract can lead to higher levels of background binding.
? trouBlesHootInG
35|
Wash the column by adding 10 ml of buffer 3 with 0.5× protease inhibitors to each column and remove the cap to allow flow through the column; re-cap the column when the buffer front is just above the bead bed.
36| Repeat
Step 26 for a total of five high-salt washes, and re-cap the column when the buffer front is just above the bead bed.
37|
Wash the column once more by adding 10 ml of buffer 4, and allow flow-through by removing the cap. For this final wash, allow the buffer to flow out of the column completely and then re-cap it.
38|
Immediately add 250 µl of room temperature elution buffer, and transfer the columns to room temperature and incubate for 10 min.  crItIcal step Ensure that the column cap is well placed and that there is no leakage; wrapping the junction with Parafilm will ensure a tight seal.
39|
Remove the cap, allow the entire volume to flow through the bead bed, capture the eluted material in a 1.5-ml Eppendorf tube and place it on ice.
40| Re-cap the column, add 250 µl of room temperature elution buffer to the column and incubate it at room temperature for 10 min. Remove the cap and capture the eluted material in the same Eppendorf tube as the first elution and return the tube to ice. Repeat elution with 250 µl for a total of three elutions with a combined volume of 750 µl total. 42| Add TCA to a final concentration of 20% (vol/vol), vortex it well and incubate the tubes on ice at 4 °C overnight.
43|
Centrifuge the tubes at >14,000g for 30 min at 4 °C in a microcentrifuge. ? trouBlesHootInG
44|
Remove the supernatant and wash the pellet with 500 µl of ice-cold acetone.
45|
Centrifuge the tube at >14,000g for 5 min at 4 °C.
46|
Remove the acetone and repeat
Step 38.
47|
Carefully remove all of the residual acetone and completely air-dry the pellet at room temperature.  pause poInt The dried pellets can be stored at −80 °C for up to 1 month.
sample preparation for Ms analysis • tIMInG 6 h 48| Resuspend the protein pellet in 50 µl of urea buffer and vortex for 1 h.
49|
Add 50 µl of 0.2% (wt/vol) ProteaseMAX in AMBC buffer and vortex the mixture for >2 h.
50| Add 1 µl of TCEP buffer and vortex the mixture for >30 min.
51| Add 2 µl of IAA buffer and incubate the mixture in the dark for 20 min.
52| Add 5 µl of TCEP buffer.
53|
Add 150 µl of AMBC.  crItIcal step Urea must be diluted to <2 M to ensure enzymatic activity.
54| Add 2.5 µl of 1% (wt/vol) proteaseMAX.
55| Add 2 µg of sequencing-grade trypsin and incubate the mixture at 37 °C with shaking overnight.
56|
Recover the tubes and store them at −80 °C.  crItIcal step Do not acidify the samples before freezing; doing so can result in near complete loss of peptides owing to acid hydrolysis.  pause poInt The dried pellets can be stored at −80 °C for up to 1 month.
preparation and loading of Hplc columns • tIMInG 3 h 57| Thaw the protein digest and acidify to a 5% (vol/vol) final concentration with formic acid.
58|
Centrifuge the peptides for 15 min and transfer the supernatant to a new tube.
59|
Load the sample onto the column with the bomb at a pressure of 500-1,000 p.s.i.; this typically takes 45 min-1 h.  pause poInt The loaded column can be stored at 4 °C for 1 week.
60|
Wash the loaded column for 30 min with buffer A.  pause poInt The washed column can be stored at 4 °C for 1 week.
61| Pack a pulled 15-cm tip made from a 100-µm glass capillary with RP resin on the bomb.
62|
Wash the analytical tip with buffer B for 15 min.
63|
Equilibrate the analytical tip with buffer A for 15 min.
Ms analysis • tIMInG 8-12 h per Fc 64|
Assemble the LCLC column (frit plus tip) with the union and attach it to a HPLC pump in line with MS. Flow buffer A to ensure steady flow and no leaks.
65| Execute the five-step LC/MS method through the Xcaliber software (see 'HPLC and mass spectrometer operation' in the Equipment Setup section).
Step 1 consists of increasing percentages of buffer B, which will move the peptides from the RP trap to SCX and wash the column. 67| Upload .RAW and MS2 files into the IP2 software. Similar software such as Scaffold will also work, but it may require a different extracted file format such as XML.
68|
Perform a Sequest database search with the appropriate protein database and parameters 6 . We recommend using parameters that include a fixed modification of 57.02146 on the cysteine residues. We suggest requiring peptides to be half or fully tryptic, with unlimited missed cleaves, and >6 aa residues in length.
69|
Filter each data set with DTASelect on the basis of a target-decoy (forward-reverse amino acid sequence protein database) approach to ensure a 1-5% false discovery rate at the protein level 35 . antIcIpateD results Ecto-Fc MS is a straightforward and sensitive interaction screen that can identify novel ligand-receptor interactions [10] [11] [12] .
70|
The production of ecto-Fc baits is uncomplicated, and assessing the ecto-Fcs is achieved by gel electrophoresis with Coomassie staining and, if necessary, MS (Fig. 2b,c) . The ecto-Fc proteins should migrate at the appropriate molecular weight and ideally be present as a single species. The identification of ligand-receptor interactions with antibodies can be problematic owing to the presence of high levels of nonspecific background proteins (Fig. 4a) . For each ecto-Fc MS experiment, the most abundant protein in each data set should be the bait Fc protein, which serves as a key internal standard (Fig. 4b) . Typically, the bait protein should be identified by hundreds to thousands of spectral counts in each analysis. Background subtraction using the Fc-alone negative control data sets should aid in the identification of low-abundance or low-affinity interactions 10 (Fig. 4c) . In regards to the limit of sensitivity of ecto-Fc MS, thus far, all three of our published interactions have been of relatively high affinity, with a measured K d in the low nanomolar range 11, 12, 36 . Thus, we consider that the method is ideally suited to isolate low nanomolar to low molar affinity complexes. It is likely that mid-or high-micromolar affinity complexes will be lost during the washes, and 'native' already bound complexes with higher affinity may not dissociate during the extraction, and thus they may not be available for capture and identification by ecto-Fc MS. A powerful approach to verifying candidate ligand-receptor interactions is to generate a bait Fc protein for the candidate receptor and to test whether the original bait can be identified by MS in a reciprocal ecto-Fc MS assay as prey. For the most confident ligand-receptor pairs, the bait and prey will be the most abundant proteins in both data sets, with each as bait in one condition and prey in the other (Fig. 5) . Other ligands may form trimetric or binary trans-interactions with multiple receptors (Fig. 5b) . Negative results should be considered with extreme caution, as there are many possible reasons why this approach may fail even though a high-affinity receptor exists (table 1) .
It is highly important to interpret each data set carefully considering replicate purifications and controls when available. In replicate experiments, nonspecific binding proteins are often identified sporadically, whereas true receptors are repeatedly identified proteins in the purified material but absent from the Fc control purifications. In some ecto-Fc MS experiments, the ligand-receptor interaction can be identified from a single experiment; however, some challenging proteins may require optimized conditions. Nonetheless, we have found ecto-Fc MS to be a successful approach for revealing new ligand-receptor interactions for many synaptic proteins. In both a and b, plots show the frequency of detection of all peptides (total spectra count, ''spec no.'') for proteins identified in both ecto-Fc MS experiments.
